Flagship Harbor Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$861K Buy
11,006
+100
+0.9% +$7.82K 0.04% 336
2025
Q1
$790K Sell
10,906
-307
-3% -$22.3K 0.04% 326
2024
Q4
$830K Sell
11,213
-1,932
-15% -$143K 0.04% 313
2024
Q3
$867K Buy
+13,145
New +$867K 0.05% 293
2024
Q1
$1.1M Buy
11,477
+12
+0.1% +$1.15K 0.07% 236
2023
Q4
$874K Buy
11,465
+1,199
+12% +$91.4K 0.06% 253
2023
Q3
$711K Buy
10,266
+907
+10% +$62.8K 0.06% 257
2023
Q2
$883K Sell
9,359
-159
-2% -$15K 0.07% 235
2023
Q1
$787K Buy
9,518
+331
+4% +$27.4K 0.07% 256
2022
Q4
$685K Buy
9,187
+1,355
+17% +$101K 0.07% 268
2022
Q3
$647K Buy
7,832
+335
+4% +$27.7K 0.08% 254
2022
Q2
$713K Sell
7,497
-147
-2% -$14K 0.08% 258
2022
Q1
$900K Sell
7,644
-90
-1% -$10.6K 0.09% 237
2021
Q4
$1M Sell
7,734
-218
-3% -$28.2K 0.09% 233
2021
Q3
$824K Hold
7,952
0.09% 247
2021
Q2
$824K Sell
7,952
-704
-8% -$73K 0.09% 248
2021
Q1
$724K Buy
8,656
+471
+6% +$39.4K 0.08% 256
2020
Q4
$747K Sell
8,185
-71
-0.9% -$6.48K 0.09% 225
2020
Q3
$658K Buy
8,256
+921
+13% +$73.4K 0.09% 216
2020
Q2
$506K Buy
7,335
+717
+11% +$49.5K 0.07% 254
2020
Q1
$416K Buy
6,618
+1,758
+36% +$111K 0.08% 231
2019
Q4
$378K Sell
4,860
-195
-4% -$15.2K 0.07% 288
2019
Q3
$370K Sell
5,055
-552
-10% -$40.4K 0.07% 272
2019
Q2
$345K Buy
5,607
+444
+9% +$27.3K 0.07% 276
2019
Q1
$329K Buy
5,163
+48
+0.9% +$3.06K 0.07% 288
2018
Q4
$261K Sell
5,115
-54
-1% -$2.76K 0.06% 293
2018
Q3
$294K Buy
5,169
+15
+0.3% +$853 0.05% 323
2018
Q2
$250K Sell
5,154
-45
-0.9% -$2.18K 0.05% 338
2018
Q1
$234K Sell
5,199
-1,125
-18% -$50.6K 0.07% 301
2017
Q4
$252K Buy
+6,324
New +$252K 0.07% 288